Skip to content

Clinical trials

Phase 1/2 Cholangiocarcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 1/2 Country / region: United States Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20091
20121
20143
20151
20184
20192
20204
20213
20228
20233
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11
Completed10
Recruiting10
Active, not recruiting4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
TCR2 Therapeutics2
Tango Therapeutics, Inc.2
Alaunos Therapeutics1
Alentis Therapeutics AG1
Amgen1
Arvinas Inc.1
Astellas Pharma Global Development, Inc.1
Basilea Pharmaceutica1
Beijing InnoCare Pharma Tech Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma37
Stomach Neoplasms11
Carcinoma, Non-Small-Cell Lung9
Pancreatic Neoplasms9
Biliary Tract Neoplasms8
Breast Neoplasms8
Colorectal Neoplasms8
Endometrial Neoplasms7
Ovarian Neoplasms7
Bile Duct Neoplasms6

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.